Yuvraj_pawp, Author at Pharma Advancement

As part of the 2016 Radiological Society of North America Annual Meeting (RSNA), Royal Philips announced the introduction of IntelliSpace...

The European Commission Grants VAL001 Orphan Drug Designation for the Treatment of Diffuse Large B-cell Lymphoma

by Yuvraj_pawp

23rd November 2016

Respiratorius AB (publ.) has received Orphan Drug Designation for its drug candidate VAL001 following a decision by the European Commission....

WUXI BIOLOGICS and PRIMA sign MOU and Announce Strategic Development and Manufacturing Partnership

by Yuvraj_pawp

23rd November 2016

Prima BioMed Ltd and WuXi Biologics ,a WuXi AppTec group company, and a leading open-access R&D capability and technology platform...

Georgia Healthcare Group says to buy JSC ABC Pharmacia

by Yuvraj_pawp

22nd November 2016

Georgia Healthcare Group PLC announces that it has signed a Sale and Purchase Agreement , subject to competition agency approval,...

FDA approves Novo Nordisk’s diabetes drug

by Yuvraj_pawp

22nd November 2016

Novo Nordisk A/S said the U.S. FDA approved on Monday its diabetes drug, Xultophy.The Danish drug maker said it planned...

Shire to Establish Rare Disease Innovation Hub in Cambridge, Mass.

by Yuvraj_pawp

22nd November 2016

Shire plc announced that it will expand its operations in Cambridge, Massachusetts, establishing a rare disease innovation hub and increasing...

Arog Pharmaceuticals Receives Orphan Drug Designation in the European Union for Crenolanib

by Yuvraj_pawp

22nd November 2016

Arog Pharmaceuticals, Inc , a privately held, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs to...

Teva Secures EU Approval of Trisenox for First Line Treatment of Low to Intermediate Risk Acute Promyelocytic Leukemia

by Yuvraj_pawp

21st November 2016

Teva Pharmaceutical Industries Ltd announced it has obtained approval from the European Commission for an indication extension of Trisenox® (arsenic...

Sandoz’s Erelzi receives FDA Approval making it the First US Enbrel Biosimilar

by Yuvraj_pawp

21st November 2016

Sandoz, a Novartis company, has announced its drug, Erelzi, has been approved by the FDA, in a significant development. ...

Novartis Buys U.S. Sickle Cell Drugmaker Selexys

by Yuvraj_pawp

21st November 2016

Novartis is buying U.S.based Selexys Pharmaceuticals in a deal worth up to $665 million, the Swiss drugmaker said on Monday,...

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

AI Revolutionizing Drug Discovery and Clinical Development

China’s Super Me-Too Drug Development: A New Pharma Frontier

Asia Pacific Omics-Based Clinical Trials Market Growth

AstraZeneca Eyes Acquisition To Develop Cell Therapies

Advanced Instruments All Set To Merge With Nova Biomedical

Taiho Pharmaceutical Buys Araris Biotech AG For $740 Million

Oracle Wins the Asia Pacific Biopharma Excellence Awards

Continuous Manufacturing is Improving Biopharma Production

AI in Drug Commercialization Market to Grow CAGR 24% by 2032

AI Revolutionizing Drug Discovery and Clinical Development

China’s Super Me-Too Drug Development: A New Pharma Frontier

Asia Pacific Omics-Based Clinical Trials Market Growth

AstraZeneca Eyes Acquisition To Develop Cell Therapies

Advanced Instruments All Set To Merge With Nova Biomedical

Taiho Pharmaceutical Buys Araris Biotech AG For $740 Million

Oracle Wins the Asia Pacific Biopharma Excellence Awards

Continuous Manufacturing is Improving Biopharma Production

AI in Drug Commercialization Market to Grow CAGR 24% by 2032

Yuvraj_pawp

Philips enhances neurological diagnosis with the launch of IntelliSpace Portal 9.0

The European Commission Grants VAL001 Orphan Drug Designation for the Treatment of Diffuse Large B-cell Lymphoma

WUXI BIOLOGICS and PRIMA sign MOU and Announce Strategic Development and Manufacturing Partnership

Georgia Healthcare Group says to buy JSC ABC Pharmacia

FDA approves Novo Nordisk’s diabetes drug

Shire to Establish Rare Disease Innovation Hub in Cambridge, Mass.

Arog Pharmaceuticals Receives Orphan Drug Designation in the European Union for Crenolanib

Teva Secures EU Approval of Trisenox for First Line Treatment of Low to Intermediate Risk Acute Promyelocytic Leukemia

Sandoz’s Erelzi receives FDA Approval making it the First US Enbrel Biosimilar

Novartis Buys U.S. Sickle Cell Drugmaker Selexys

Qucik Links

About Us

Subscribe Us

System

Resources

Retrieve your password